Cytoreductive surgery in the primary management of advanced epithelial ovarian carcinoma: A topic for debate

被引:9
作者
Girling, JC
Soutter, WP
机构
[1] Inst. of Obstetrics and Gynaecology, Hammersmith Hospital, London W12 0HS, Du Cane Road
关键词
advanced ovarian carcinoma; cytoreductive surgery;
D O I
10.1046/j.1525-1438.1996.06020081.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
While there is no doubt that surgical resection of early stage ovarian cancer can be curative, the effect of cytoreductive surgery on the prognosis in advanced disease is less certain. A recent EORTC study does suggest that intervention debulking surgery might improve survival and this requires urgent confirmation. Extensive cytoreductive surgery, removing bowel, parts of the urinary tract or lymph nodes, may have little impact on the survival of women with advanced disease and can result in substantial morbidity. Discretion and experience are required in determining the appropriate radicality of tumor resection to avoid predictable impairment of quality of life.
引用
收藏
页码:81 / 84
页数:4
相关论文
共 50 条
  • [31] Primary Surgery or Interval Debulking for Advanced Epithelial Ovarian Cancer: Does It Matter?
    Markauskas, Algirdas
    Mogensen, Ole
    Christensen, Rene dePont
    Jensen, Pernille Tine
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (08) : 1420 - 1428
  • [32] Nomogram for 30-day morbidity after primary cytoreductive surgery for advanced stage ovarian cancer
    Nieuwenhuyzen-de Boer, G. M.
    Gerestein, C. G.
    Eijkemans, M. J. C.
    Burger, C. W.
    Kooi, G. S.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2016, 37 (01) : 63 - 68
  • [33] Long-term survival in advanced ovarian carcinoma following cytoreductive surgery with standard peritonectomy procedures
    Tentes, AAK
    Mirelis, CG
    Markakidis, SK
    Bekiaridou, KA
    Bougioukas, IG
    Xanthoulis, AI
    Tsalkidou, EG
    Zafiropoulos, GH
    Nikas, IH
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 (02) : 490 - 495
  • [34] Appendectomy with cytoreductive surgery for ovarian and type 2 endometrial carcinoma
    Wong, L. F. A.
    Wahab, N. A.
    Gleeson, N.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2014, 35 (02) : 143 - 148
  • [35] Cytoreductive Surgery and Intraperitoneal Chemohyperthermia for Chemoresistant and Recurrent Advanced Epithelial Ovarian Cancer: Prospective Study of 81 Patients
    Eddy Cotte
    Olivier Glehen
    Faheez Mohamed
    Franck Lamy
    Claire Falandry
    François Golfier
    Francois Noel Gilly
    World Journal of Surgery, 2007, 31 : 1813 - 1820
  • [36] Cytoreductive Surgery Plus HIPEC in Recurrent or Newly Diagnosed Advanced Epithelial Ovarian Cancer: a Meta-analysis
    Taliento, C.
    Restaino, S.
    Arcieri, M.
    Scutiero, G.
    Greco, P.
    Scambia, G.
    Vizzielli, G.
    ANNALS OF SURGICAL ONCOLOGY, 2025, : 3648 - 3659
  • [37] Prediction of 30-day morbidity after primary cytoreductive surgery for advanced stage ovarian cancer
    Gerestein, C. G.
    Nieuwenhuyzen-de Boer, G. M.
    Eijkemans, M. J.
    Kooi, G. S.
    Burger, C. W.
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (01) : 102 - 109
  • [38] Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer
    Helm, C. William
    Bristow, Robert E.
    Kusamura, Shigeki
    Baratti, Dario
    Deraco, Marcello
    JOURNAL OF SURGICAL ONCOLOGY, 2008, 98 (04) : 283 - 290
  • [39] Cytoreductive surgery after recurrent epithelial ovarian cancer and at other timepoints
    Paolo Sammartino
    Tommaso Cornali
    Marialuisa Framarino dei Malatesta
    Pompiliu Piso
    World Journal of Obstetrics and Gynecology, 2013, (04) : 101 - 107
  • [40] The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concems
    Park, Jeong-Yeol
    Seo, Sang-Soo
    Kang, Sokbom
    Lee, Kwang Beom
    Lim, So Yi
    Choi, Hyo Seomg
    Park, Sang-Yoon
    GYNECOLOGIC ONCOLOGY, 2006, 103 (03) : 977 - 984